Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,580.69
930.59
859.23
888.55
1,837.94
865.40
787.31
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,580.69
930.59
859.23
888.55
1,837.94
865.40
787.31
Raw Material Cost
577.18
501.42
407.33
380.25
545.93
493.45
376.42
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.89
2.76
2.74
1.57
3.17
3.70
4.50
Selling and Distribution Expenses
563.10
158.77
49.11
193.73
598.20
148.32
69.86
Other Expenses
7.24
8.15
5.30
10.77
5.21
5.45
5.44
Total Expenditure (Excl Depreciation)
1,213.57
744.40
512.22
683.28
1,199.42
699.95
505.22
Operating Profit (PBDIT) excl Other Income
367.1
186.20000000000002
347
205.3
638.5
165.5
282.1
Other Income
26.17
35.15
33.80
16.97
43.26
51.45
54.62
Operating Profit (PBDIT)
382.10
292.61
451.90
207.34
739.90
274.80
395.26
Interest
0.89
2.76
2.74
1.57
3.17
3.70
4.50
Exceptional Items
4.83
7.05
5.45
9.31
4.27
9.89
9.46
Gross Profit (PBDT)
1,003.51
429.16
451.89
508.30
1,292.01
371.95
410.89
Depreciation
0.00
70.04
70.04
69.20
69.20
66.92
66.92
Profit Before Tax
386.04
226.87
384.57
145.89
671.80
214.07
333.30
Tax
55.96
28.01
60.74
-4.46
102.46
31.14
54.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
268.56
202.72
313.14
164.19
483.46
178.42
261.77
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
268.56
202.72
313.14
164.19
483.46
178.42
261.77
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
36.45
-3.86
10.70
-19.88
78.92
-4.02
12.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
305.01
198.86
323.83
144.31
562.38
174.40
274.37
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
0.0
1.0
1.0
1.0
1.0
1.0
Reserves
11,371.87
12,013.17
12,172.14
11,858.78
11,697.01
11,249.89
11,631.48
Earnings per share (EPS)
0.15
0.11
0.17
0.09
0.26
0.1
0.14
Diluted Earnings per share
0.15
0.11
0.17
0.09
0.26
0.1
0.14
Operating Profit Margin (Excl OI)
22.52%
20.14%
40.51%
13.64%
34.14%
18.08%
34.77%
Gross Profit Margin
24.42%
31.91%
52.91%
24.21%
40.32%
32.47%
50.83%
PAT Margin
16.99%
21.78%
36.44%
18.48%
26.3%
20.62%
33.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 69.86% vs 8.31% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is 53.34% vs -38.57% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is 38.21% vs -38.41% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -67.86% vs 3.70% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
Compare Quarterly Results Of Hualan Biological Engineering, Inc. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
1,580.69
0
1,580.69
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,580.69
0
1,580.69
Raw Material Cost
577.18
0
577.18
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.89
0
0.89
Selling and Distribution Expenses
563.10
0
563.10
Other Expenses
7.24
0.00
7.24
Total Expenditure (Excl Depreciation)
1,213.57
0
1,213.57
Operating Profit (PBDIT) excl Other Income
367.12
0.00
367.12
Other Income
26.17
0
26.17
Operating Profit (PBDIT)
382.10
0
382.10
Interest
0.89
0
0.89
Exceptional Items
4.83
0
4.83
Gross Profit (PBDT)
1,003.51
0
1,003.51
Depreciation
0.00
0
0.00
Profit Before Tax
386.04
0
386.04
Tax
55.96
0
55.96
Provisions and contingencies
0
0
0.00
Profit After Tax
268.56
0
268.56
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
268.56
0
268.56
Share in Profit of Associates
0
0
0.00
Minority Interest
36.45
0
36.45
Other related items
0.00
0.00
0.00
Consolidated Net Profit
305.01
0
305.01
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
11,371.87
0
11,371.87
Earnings per share (EPS)
0.15
0
0.15
Diluted Earnings per share
0.15
0
0.15
Operating Profit Margin (Excl OI)
22.52%
0%
0.00
22.52%
Gross Profit Margin
24.42%
0%
0.00
24.42%
PAT Margin
16.99%
0%
0.00
16.99%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 158.07 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 69.86% vs 8.31% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -13.99% vs -20.60% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 30.50 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 53.34% vs -38.57% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -45.77% vs -20.81% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 35.59 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 38.21% vs -38.41% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -48.91% vs -21.54% in Sep 2024
Quarterly - Interest
Interest 0.09 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is -67.86% vs 3.70% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -71.88% vs -8.57% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.52%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
